Naresh Ramireddy, Ph.D., applies his technical expertise in organic chemistry and medicinal chemistry to assist clients in their important patent prosecution and intellectual property matters.

Prior to joining Cantor Colburn, Naresh worked as Principal Scientist and a patent scientist for more than ten years at Vijaya Pharmaceuticals. This experience immersed him in all aspects of custom synthesis of novel organic molecules. As a principal scientist, he led extensive research in developing novel small molecule Cyclin-dependent kinase inhibitors (CDK) to treat breast cancer and its subtypes. He advanced multiple projects through various stages of drug discovery, including target identification, hit-finding enablement, hit-to-lead, and lead optimization. Naresh is a co-inventor for several patents in this area. During his tenure as patent scientist at Vijaya Pharmaceuticals, Naresh gained immense experience in drafting patent applications, amending claims and in preparing responses to office actions. He also worked extensively on patentability analysis, due diligence, and prior art searches.  His expertise also extends to identifying and assessing inventions with potential for new product development and analyzing patents and scientific papers to support patent preparation.        

Naresh completed his doctoral studies at the University of Texas at San Antonio under the guidance of Professor John C.-G. Zhao, Ph.D. His graduate research focused on developing organo-catalyzed, enantioselective methods for synthesizing chromenes and spirooxindole derivatives. During his time as a graduate student, he also taught organic chemistry to undergraduates and mentored several graduate students in their research projects. His work reflects a strong foundation in stereoselective synthesis and a commitment to academic teaching and mentorship.

Professional Affiliations

American Chemical Society

Intellectual Property Owners Association (IPO)

North Carolina Bar Association